Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QSC: Questcor Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (3)	11/16/2001 7:29:51 PM
From: Crossy	Respond to of 4

Harold, sorry to reply so late.. Why QSC is attractive ? It'S a specialty pharma company with a major connection : SigmaTau (think it's Italian). The neg. book value and lack of cash is a fact of the past, not anymore, there were some private placements this summer. Gruntal thinx they will be getting earnings positive somewhen next year. And their pipeline is quite ok, I noticed they even added a late stage 3 candidate in the last months.. And they were able to tap niche formulations by acquiring those undermarketed by others. Revenues are trending up nicely.. stay tuned ! (Reminds me somewhat of Amarin AMRN - was trading sub $4 also and look where it'S now - specialty pharmas are really a nice place to be right now..) rgrds CROSSY